Kalshi has partnered with AppliedXL to launch prediction markets on clinical trials and FDA decisions.
Kalshi has teamed up with public intelligence firm AppliedXL to introduce a pilot series of prediction markets linked to clinical trial results and FDA regulatory determinations. This endeavor, designed as a trial initiative, offers traders the opportunity to wager on specific drug programs rather than on the company's stock. The average expense of bringing a single drug to the market is approximately $2.3...
